BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21480313)

  • 1. Statins increase the risk of prostate cancer: a population-based case-control study.
    Chang CC; Ho SC; Chiu HF; Yang CY
    Prostate; 2011 Dec; 71(16):1818-24. PubMed ID: 21480313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins are associated with a reduced risk of gastric cancer: a population-based case-control study.
    Chiu HF; Ho SC; Chang CC; Wu TN; Yang CY
    Am J Gastroenterol; 2011 Dec; 106(12):2098-103. PubMed ID: 21844922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin use and the risk of pancreatic cancer: a population-based case-control study.
    Chiu HF; Chang CC; Ho SC; Wu TN; Yang CY
    Pancreas; 2011 Jul; 40(5):669-72. PubMed ID: 21654539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin use and the risk of female lung cancer: a population-based case-control study.
    Cheng MH; Chiu HF; Ho SC; Yang CY
    Lung Cancer; 2012 Mar; 75(3):275-9. PubMed ID: 21958449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin use and the risk of gallstone disease: a population-based case-control study.
    Chiu HF; Chen CC; Kuo HW; Lee IM; Wu TN; Yang CY
    Expert Opin Drug Saf; 2012 May; 11(3):369-74. PubMed ID: 22243480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin use and the risk of bladder cancer: a population-based case-control study.
    Kuo CC; Chiu HF; Lee IM; Kuo HW; Lee CT; Yang CY
    Expert Opin Drug Saf; 2012 Sep; 11(5):733-8. PubMed ID: 22849562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin use and the risk of kidney cancer: a population-based case-control study.
    Chiu HF; Kuo CC; Kuo HW; Lee IM; Lee CT; Yang CY
    Expert Opin Drug Saf; 2012 Jul; 11(4):543-9. PubMed ID: 22502740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin use and the risk of esophageal cancer: a population-based case-control study.
    Chan TF; Chiu HF; Wu CH; Lin CL; Yang CY
    Expert Opin Drug Saf; 2013 May; 12(3):293-8. PubMed ID: 23470154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins and prostate cancer risk: a case-control study.
    Shannon J; Tewoderos S; Garzotto M; Beer TM; Derenick R; Palma A; Farris PE
    Am J Epidemiol; 2005 Aug; 162(4):318-25. PubMed ID: 16014776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin use and the risk of breast cancer: a population-based case-control study.
    Chan TF; Wu CH; Lin CL; Yang CY
    Expert Opin Drug Saf; 2014 Mar; 13(3):287-93. PubMed ID: 24490820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study.
    Murtola TJ; Tammela TL; Lahtela J; Auvinen A
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2226-32. PubMed ID: 18006910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Previous Exposure to Statin May Reduce the Risk of Subsequent Non-Hodgkin Lymphoma: A Nationwide Population-Based Case-Control Study.
    Cho SF; Yang YH; Liu YC; Hsiao HH; Huang CT; Wu CH; Tsai YF; Wang HC; Liu TC
    PLoS One; 2015; 10(10):e0139289. PubMed ID: 26425850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
    Koro CE; Sowell MO; Stender M; Qizilbash N
    Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins reduce the risk of pancreatic cancer in humans: a case-control study of half a million veterans.
    Khurana V; Sheth A; Caldito G; Barkin JS
    Pancreas; 2007 Mar; 34(2):260-5. PubMed ID: 17312467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin drugs and risk of advanced prostate cancer.
    Platz EA; Leitzmann MF; Visvanathan K; Rimm EB; Stampfer MJ; Willett WC; Giovannucci E
    J Natl Cancer Inst; 2006 Dec; 98(24):1819-25. PubMed ID: 17179483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin use and risk of prostate cancer: a Danish population-based case-control study, 1997-2010.
    Jespersen CG; Nørgaard M; Friis S; Skriver C; Borre M
    Cancer Epidemiol; 2014 Feb; 38(1):42-7. PubMed ID: 24275259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Height, urban-born and prostate cancer risk in Japanese men.
    Minami Y; Tochigi T; Kawamura S; Tateno H; Hoshi S; Nishino Y; Kuwahara M
    Jpn J Clin Oncol; 2008 Mar; 38(3):205-13. PubMed ID: 18272473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity, adipokines, and prostate cancer in a prospective population-based study.
    Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
    Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
    Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cigarette smoking and risk of prostate cancer in middle-aged men.
    Plaskon LA; Penson DF; Vaughan TL; Stanford JL
    Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):604-9. PubMed ID: 12869398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.